WHO classification of tumors of soft tissue

Changed by Arlene Campos, 27 Jun 2024 at 7:54 AM UTC
Disclosures - updated 10 Jun 2024: Nothing to disclose

Updates to Article Attributes

Title was changed:
WHO classification of tumorstumours of soft tissue
Body was changed:

The World World Health Organisation (WHO) classification of soft tissue tumours is is the most widely used pathology-based classification system for such disorders. The current The revision, part of the 5th edition of the WHO classification of soft tissue and bone tumours (volume 3), was published in 2020 and is reflected in the article below 1.

Classification

Adipocytic tumours
Fibroblastic/myofibroblastic tumours
So-called fibrohistiocytic tumours
Vascular tumours
Pericytic (perivascular) tumours
Smooth muscle tumours
Skeletal-muscle tumours
Gastrointestinal stromal tumours
Chondro-osseous tumours
Peripheral nerve sheath tumours
Tumours of uncertain differentiation

Changes from the prior version

New entitiesEntities and variants

Newly introduced entitiesEntities include the following 1-5:

Other changes
  • melanotic schwannoma: now renamed to malignant melanotic nerve sheath tumour

  • dedifferentiated liposarcoma: adverse prognostic impact of myogenic and rhabdomyoblastic differentiation as well of a high grade on the FNCLCC (French Federation of Cancer Centres Sarcoma Group) grading system

  • solitary fibrous tumour: 'extrapleural' has been removed

  • -<p>The<strong> World Health Organisation (WHO) classification of soft tissue tumours</strong> is the most widely used pathology-based classification system for such disorders. The current revision, part of the 5th edition of the WHO classification of soft tissue and bone tumours (volume 3), was published in 2020 and is reflected in the article below <sup>1</sup>.</p><h4>Classification</h4><h5>Adipocytic tumours</h5><ul>
  • +<p>The<strong>&nbsp;World Health Organisation (WHO) classification of soft tissue tumours</strong>&nbsp;is the most widely used pathology-based classification system for such disorders.&nbsp;The revision, part of the 5th edition of the WHO classification of soft tissue and bone tumours (volume 3), was published in 2020 and is reflected in the article below <sup>1</sup>.</p><h4>Classification</h4><h5>Adipocytic tumours</h5><ul>
  • -<li><p><a href="/articles/lipoblastoma">lipoblastoma</a> and <a href="/articles/lipoblastomatosis">lipoblastomatosis</a></p></li>
  • +<li><p><a href="/articles/lipoblastoma">lipoblastoma</a>&nbsp;and <a href="/articles/lipoblastomatosis">lipoblastomatosis</a></p></li>
  • -<li><p><a href="/articles/intramuscular-hemangiomas">intramuscular haemangioma</a></p></li>
  • +<li><p><a href="/articles/intramuscular-haemangiomas">intramuscular haemangioma</a></p></li>
  • -<li><p><a href="/articles/lymphatic-malformations-1">lymphangioma</a> and <a href="/articles/lymphangiomatosis">lymphangiomatosis</a></p></li>
  • +<li><p><a href="/articles/lymphatic-malformations-1">lymphangioma</a>&nbsp;and <a href="/articles/lymphangiomatosis">lymphangiomatosis</a></p></li>
  • -<li><p><a href="/articles/ectopic-meningioma">ectopic meningioma</a> and <a href="/articles/meningothelial-hamartoma">meningothelial hamartoma</a></p></li>
  • +<li><p><a href="/articles/ectopic-meningioma">ectopic meningioma</a>&nbsp;and <a href="/articles/meningothelial-hamartoma">meningothelial hamartoma</a></p></li>
  • -</ul><h4>Changes from the prior version</h4><h5>New entities and variants</h5><p>Newly introduced entities include the following <sup>1-5</sup>:</p><ul>
  • +</ul><h4>Changes from the prior version</h4><h5>Entities and variants</h5><p>Entities include the following <sup>1-5</sup>:</p><ul>
  • -<li><p><a href="/articles/epithelioid-haemangioendothelioma-2" title="Epithelioid haemangioendothelioma">epithelioid haemangioendothelioma</a> features two newly recognised subtypes</p></li>
  • +<li><p><a href="/articles/epithelioid-haemangioendothelioma-2" title="Epithelioid haemangioendothelioma">epithelioid haemangioendothelioma</a> features two recognised subtypes</p></li>
  • -<ul><li><p>myopericytoma, including myofibroma - new subtype: cellular myofibroma/myopericytoma</p></li></ul>
  • +<ul><li><p>myopericytoma, including myofibroma - subtype:&nbsp;cellular myofibroma/myopericytoma</p></li></ul>
  • -<ul><li><p><a href="/articles/spindle-cell-rhabdomyosarcoma">spindle cell/sclerosing rhabdomyosarcoma</a> - three subtypes</p></li></ul>
  • +<ul><li><p><a href="/articles/spindle-cell-rhabdomyosarcoma">spindle cell/sclerosing rhabdomyosarcoma</a>&nbsp;-&nbsp;three subtypes</p></li></ul>

References changed:

  • 7. Ahlawat S & Fayad L. Revisiting the WHO Classification System of Soft Tissue Tumours: Emphasis on Advanced Magnetic Resonance Imaging Sequences. Part 1. Pol J Radiol. 2020;85:e396-408. <a href="https://doi.org/10.5114/pjr.2020.98685">doi:10.5114/pjr.2020.98685</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/32999693">Pubmed</a>
  • 7. Ahlawat S & Fayad L. Revisiting the WHO Classification System of Soft Tissue Tumours: Emphasis on Advanced Magnetic Resonance Imaging Sequences. Part 1. Pol J Radiol. 2020;85(1):e396-408. <a href="https://doi.org/10.5114/pjr.2020.98685">doi:10.5114/pjr.2020.98685</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/32999693">Pubmed</a>

Updates to Primarylink Attributes

Type was set to PrimaryLink.
Visible was set to true.
Content was set to 10620.

Updates to Link Attributes

Title was removed:
WHO classification of tumors of soft tissue
Type was removed.
Visible changed from true to false.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.